Autologous muscle precursor cell therapy（MUVON Therapeutics）

N/A

Report date: 2025/12/09 15:41:45

Base Information

Drug NameAutologous muscle precursor cell therapy（MUVON Therapeutics）

Drug Alias NameMPCCOL

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Muscle precursor cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsUrinary Incontinence, Stress

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMuvon Therapeutics AG

China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Zurich

Inactive CompaniesN/A

Active IndicationsUrinary Incontinence, Stress

Inactive IndicationsN/A

Other Information

ATC CodeN/A